Dexamethasone cyclophosphamid pulse therapy in pemphigus-appraisal of its outcome
Introduction :- Pemphigus is the commonest autoimmune vesicobullous disorder on the the Indian subcontinent. the mainstay of treatment of the disease is systemic steroid and other immunosuppresive therapies. Dexamethasone-cyclophosphamide(DCP) pulse therapy was designated by pasricha for pemphigus i...
Main Authors: | Prabhash Kulhari, Urmila Baruah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Dermatology Online Journal |
Subjects: | |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2012;volume=3;issue=10;spage=9;epage=9;aulast=Kulhari |
Similar Items
-
Pulse therapy in pemphigus: report of 11 cases
by: Nurimar Conceicao Fernandes, et al.
Published: (2013-08-01) -
A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021-01-01) -
Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study
by: Ludmilla Figueiredo Fontenelle, et al.
Published: (2023-11-01) -
Prospective study of pulse therapy in childhood pemphigus disorders
by: Bhumesh Kumar Katakam, et al.
Published: (2018-01-01) -
Pulse therapy in pemphigus: Ready reckoner
by: Anil Abraham, et al.
Published: (2016-01-01)